AAVarta® AAV capsid in silico evolution discovery platform

Constellation® AI aided DNA expression cassette design platform

Progress® Data-driven protein engineering platform

Commercial-scale manufacturing capabilities

Developing the most advanced one-time curative, safe and effective gene and cell therapies for patients around the world.

Exegenesis Bio is a clinical-stage global cell and gene therapy company that operates in Philadelphia, Boston, China, and Singapore. Founded in 2019 with strong financial backing, the company has built a broad pipeline of innovative genetic medicines and fully integrated manufacturing capabilities. The company is advancing an early to clinical-stage gene therapy pipeline with three initial focused therapeutic areas: CNS, ophthalmology, and Liver. The company’s vision is to develop and increase access to gene and cell therapies for patients around the world.

Scroll to top